Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016]
- PMID: 37019803
- DOI: 10.1016/j.leukres.2023.107073
Corrigendum to "Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update" [Leukemia Research 125 (2023) 107016]
Erratum for
-
Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update.Leuk Res. 2023 Feb;125:107016. doi: 10.1016/j.leukres.2023.107016. Epub 2023 Jan 5. Leuk Res. 2023. PMID: 36634577 Review.
Publication types
LinkOut - more resources
Full Text Sources